Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase 1/2 3Phase 1 2Phase 4 1Phase 3 1

Status

Completed 46Recruiting 14Active not recruiting 13Terminated 11Withdrawn 4Unknown 2Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Laryngeal Neoplasms 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Cyclophosphamide 51fludarabine 38Injections 32Gemcitabine 25Paclitaxel 24Cisplatin 22Radiotherapy 19toripalimab 18pembrolizumab 18Carboplatin 17Capecitabine 17Fluorouracil 15Oxaliplatin 14Nivolumab 14Docetaxel 12camrelizumab 11apatinib 11Temozolomide 11Immunotherapy, Adoptive 11Cetuximab 11Bevacizumab 10Irinotecan 9Drug Therapy 9sintilimab 8Etoposide 8aldesleukin 7Taxes 7Rituximab 7Radiosurgery 7Peripheral Blood Stem Cell Transplantation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Unknown × olaparib × Clear all
NCT02229656 2023-11-07

Olaparib and Radiotherapy in Head and Neck Cancer

The Netherlands Cancer Institute

Phase 1 Unknown
12 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms

NCT01460888 2013-08-19

ROCOCO

The Christie NHS Foundation Trust

Phase 1 Unknown
36 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡